Steven Woloshin, MD
Title(s)
Professor of The Dartmouth Institute
Professor of Medicine
Professor of Community and Family Medicine
Department(s)
The Dartmouth Institute
Medicine
Community and Family Medicine
Education
Dartmouth Medical School, MS 1996
Boston University School of Medicine, MD 1987
Boston University, BA 1987
Programs
The Dartmouth Institute for Health Policy and Clinical Practice
Academic Analytics
View Profile
Contact Information
Dartmouth Medical School
HB 7900
Hanover NH 03755
Phone: 603 646 5672
Email: steven.woloshin@dartmouth.edu
Professional Interests
Dr. Woloshin's research interest is in learning how to enhance the quality of medical communication to the public, patients, physicians and policymakers. His work (in collaboration with Dr. Lisa Schwartz) has 2 main approaches: improving the quality of messages presenting health information to people, and preparing audiences to make sense of the messages they receive. His main focus is on the communication of medical statistics and information about the benefits and harms of screening and prescription drugs.
Bad news: how the media reported on an observational study about cardiovascular outcomes of COVID-19. Physicians' Perspectives On FDA Regulation Of Drugs And Medical Devices: A National Survey. The New USPSTF Mammography Recommendations - A Dissenting View. Overdiagnosis and too much medicine in a world of crises. Updating the Know Your Chances Website to Include Smoking Status as a Risk Factor for Mortality Estimates. Physician Perspectives on the Food and Drug Administration's Decision to Grant Accelerated Approval to Aducanumab for Alzheimer's Disease. Communicating health information with visual displays. Direct-to-Consumer Low-Testosterone Clinics-Where Is the Federation of State Medical Boards? Association between tobacco product use and asthma among US adults from the Population Assessment of Tobacco and Health (PATH) Study waves 2-4. Therapeutic Value of Drugs Frequently Marketed Using Direct-to-Consumer Television Advertising, 2015 to 2021. |
|